Cenicriviroc, a cytokine receptor antagonist, potentiates all-trans retinoic acid in reducing liver injury in cholestatic rodents

New therapeutic concepts in bile acid transport and signaling for management of cholestasis

(2017) Michael Trauner et al.   HEPATOLOGY

Combination Therapy of All-Trans Retinoic Acid With Ursodeoxycholic Acid in Patients With Primary Sclerosing Cholangitis

(2017) David N. Assis et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

Obeticholic Acid: First Global Approval

(2016) A. Markham et al.   DRUGS

Emerging drugs for the treatment of Primary Biliary Cholangitis

(2016) Ahmad H. Ali et al.   EXPERT OPINION ON EMERGING DRUGS

Inhibition of intestinal bile acid absorption improves cholestatic liver and bile duct injury in a mouse model of sclerosing cholangitis

(2016) Anna Baghdasaryan et al.   JOURNAL OF HEPATOLOGY

Intrahepatic cholestasis of pregnancy (ICP): case report and review of the literature

(2016) V. Keitel et al.   ZEITSCHRIFT FUR GASTROENTEROLOGIE

Proposed therapies in primary biliary cholangitis

(2016) Annarosa Floreani et al.   Expert Review of Gastroenterology & Hepatology

Antifibrotic Effects of the Dual CCR2/CCR5 Antagonist Cenicriviroc in Animal Models of Liver and Kidney Fibrosis

(2016) Eric Lefebvre et al.   PLoS One

Therapeutic targets for cholestatic liver injury

(2015) Benjamin L. Woolbright et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Pharmacological inhibition of apical sodium-dependent bile acid transporter changes bile composition and blocks progression of sclerosing cholangitis in multidrug resistance 2 knockout mice

(2015) Alexander G. Miethke et al.   HEPATOLOGY

IL-17A Synergistically Enhances Bile Acid–Induced Inflammation during Obstructive Cholestasis

(2013) Kate M. O'Brien et al.   AMERICAN JOURNAL OF PATHOLOGY

Genetic Determinants of Cholestasis

(2013) Gideon M. Hirschfield   Clinics in Liver Disease

Chronic cholestatic liver diseases: Clues from histopathology for pathogenesis

(2013) Marion J. Pollheimer et al.   MOLECULAR ASPECTS OF MEDICINE

Novel insight into mechanisms of cholestatic liver injury

(2012) Benjamin L Woolbright   WORLD JOURNAL OF GASTROENTEROLOGY

Bile Acids Induce Inflammatory Genes in Hepatocytes

(2011) Katryn Allen et al.   AMERICAN JOURNAL OF PATHOLOGY

Myeloperoxidase and elastase are only expressed by neutrophils in normal and in inflammed liver

(2011) Ahmad Amanzada et al.   HISTOCHEMISTRY AND CELL BIOLOGY

Combination of retinoic acid and ursodeoxycholic acid attenuates liver injury in bile duct-ligated rats and human hepatic cells

(2010) Hongwei He et al.   HEPATOLOGY

Retinoic acid represses CYP7A1 expression in human hepatocytes and HepG2 cells by FXR/RXR-dependent and independent mechanisms

(2010) Shi-Ying Cai et al.   JOURNAL OF LIPID RESEARCH

Organic Solute Transporter, OSTα-OSTβ: Its Role in Bile Acid Transport and Cholestasis

(2010) Carol Soroka et al.   SEMINARS IN LIVER DISEASE

The Spectrum of Liver Diseases Related toABCB4Gene Mutations: Pathophysiology and Clinical Aspects

(2010) Anne Davit-Spraul et al.   SEMINARS IN LIVER DISEASE

Hepatocyte Transplantation-Induced Liver Inflammation Is Driven by Cytokines-Chemokines Associated With Neutrophils and Kupffer Cells

(2009) Natan Krohn et al.   GASTROENTEROLOGY

CCR2 promotes hepatic fibrosis in mice

(2009) Ekihiro Seki et al.   HEPATOLOGY